Home/Filings/4/0001179110-19-013127
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-19-013127

CIK 0001292519other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 5:23 PM ET

Size

5.3 KB

Accession

0001179110-19-013127

Insider Transaction Report

Form 4
Period: 2019-12-19
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-12-19$0.16/sh557$8978,986 total
Footnotes (1)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 1,500 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying the unvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:23 PM ET
Size
5.3 KB